Medical technology company Healthcare Holding Schweiz AG announced on Monday that it has completed the acquisition of Effectum CH-Rep AG, effectively carving out all Swiss Authorized Representative (CH-REP) services from Effectum Medical AG.
Under the Medical Devices Ordinance (MedDO SR 812.213), medical device manufacturers without a Swiss presence must appoint a CH-REP to distribute products within Switzerland.
This acquisition enhances Healthcare Holding Schweiz AG's ability to serve as a comprehensive partner for global medical technology manufacturers. The company's expanded portfolio now includes services ranging from import and distribution to full regulatory compliance. This positions Healthcare Holding Schweiz AG to offer integrated solutions to meet evolving industry needs.
Healthcare Holding Schweiz AG acquires Effectum CH-Rep AG to expand services
Femasys receives CE mark approval for FemBloc delivery system in Europe
Aiforia secures IVDR certification for expanded AI-powered cancer diagnostics in Europe
Limaca Medical launches Precision-GI endoscopic automated motorised EUS biopsy device in US
Owens & Minor launches ByramConnect digital health platform for diabetes management
Acrivon Therapeutics receives FDA Breakthrough Device designation for ACR-368 OncoSignature assay
BrainCool secures market approval for BrainCool System in Malaysia
Bioretec Ltd secures CE mark approval for RemeOs Trauma Screw portfolio
Biohit launches FAEX Sample System for stool sample collection
Renalys Pharma completes patient enrolment for Phase III clinical trial of sparsentan
Innocan Pharma's BI Sky Global completes industry standard safety test
ColdVentures partners with Medco Sports Medicine to combat heat stroke